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Abstract.  We have examined the effects of epidermal 
growth factor (EGF), platelet-derived growth factor, 
and insulin on the differentiation of a  mouse vascular 
smooth muscle-like cell line, the BC3H1  cells. On the 
basis of cell morphology and smooth muscle a-isoac- 
tin synthesis, we demonstrate that EGF at physiologi- 
cal concentrations prevents the differentiation of these 
cells, whereas platelet-derived growth factor has no ap- 
parent effect. The induction of a-isoactin synthesis by 
serum deprivation is inhibited by EGF in a  dose-de- 
pendent manner with a half-maximal effect at 3-5 
ng/ml and a  maximal inhibition at ~-,30 ng/ml. North- 
ern analysis also shows that EGF blocks the accumula- 
tion of a-isoactin mRNA normally observed during 
cell differentiation. Addition of EGF to differentiated 
cells results in a  repression of a-isoactin synthesis, a 
stimulation of 13- and ),-isoactin synthesis, and the 
stabilization of the nonmuscle isoactins. The synthesis 
of creatine phosphokinase, a  muscle-specific noncon- 
tractile protein, is also regulated by EGF in a  similar 
fashion. Modulation by EGF of a-isoactin expression 
is not affected by aphidicolin and is therefore indepen- 
dent of its mitogenic effect on these cells. Insulin is 
not required for observation of the EGF-dependent 
effects but instead seems to promote differentiation. 
Our results show that EGF can replace serum in con- 
trolling the differentiation of BC3H1 cells. 
T 
HE growth and differentiation of vascular smooth mus- 
cle cells can be controlled by factors that are in serum 
or secreted from neighboring cells (22, 26, 34). The 
nature of the complex regulation exerted by these factors is 
an important problem both in cell biology and medicine. A 
model that has proven useful in addressing this problem is 
the BC3H1  cell line. 
BC3H1  cells,  isolated from a  mouse brain tumor (27), 
differentiate in vitro when placed in serum-free medium. 
Events occurring during the process  of differentiation in- 
clude cessation of cell proliferation, transformation from the 
morphology of fibroblasts to a long spindly shape typical of 
smooth muscle cells, and stimulation of the synthesis of sev- 
eral muscle-specific proteins such as myokinase (27), acetyl- 
choline receptor (23), creatine phosphokinase (CPK) ~  (19), 
and insulin receptor (30). These phenotypic changes induced 
by serum depletion can be prevented or reversed by addition 
of serum to the medium. 
Previous studies in our laboratory have revealed that ex- 
pression of actin isoforms in BC3H1 cells also appears to be 
developmentally regulated. Cell differentiation  in serum-free 
A preliminary account of this work was presented at the 1986 meeting of 
the American  Society  for  Cell  Biology  (1986.  J.  Cell  Biol.  103:121a. 
[Abstr.]). 
1. Abbreviations  used in this paper: CPK,  creatine phosphokinase;  EGF, 
epidermal growth factor; ILGF, insulin-like growth factor; N2SF medium, 
N2 serum-free medium; PDGF, platelet-derived growth factor. 
medium results in a selective three- to fourfold increase of 
smooth muscle a-isoactin synthesis and a five- to sixfold in- 
crease in the level of its mRNA, relative to that observed in 
undifferentiated cells (31, 32). 
Serum contains a wide variety of growth factors with vari- 
ous  effects on cells  (t,  2).  To  understand the control of 
BC3H1 cell differentiation exerted by serum, it is necessary 
to determine the roles played by individual serum growth fac- 
tors in this model system. Based on changes in the levels of 
CPK or acetylcholine receptor, two serum growth factors, 
fibroblast growth factor and I~-transforming growth factor, 
have been shown to modulate the behavior of BC3H1  cells 
(14, 21, 29). In similar experiments, epidermal growth factor 
(EGF) and platelet-derived growth factor (PDGF) were re- 
ported to have no effect on these cells (14, 21). Recently, it 
has been shown that fibroblast growth factor can exert an 
effect similar to that of serum on a-isoactin expression in 
these cells (36). 
In the work presented here, we report that results of our 
studies on the effects of EGF, PDGF, and insulin on the ex- 
pression of smooth muscle ~t-isoactin in BC3H1 cells. These 
factors have all been implicated as possibly being important 
in regulating smooth muscle cell growth (9,  16,  35).  Our 
results show that although PDGF has no significant effect on 
actin expression in BC3H1 cells, EGF, like FCS, causes an 
inhibitory effect on a-isoactin expression. This effect of EGF 
is independent of the DNA replication. 
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Materials 
L-[35S]Methionine (>800 Ci/mmol) was purchased from Amersham Corp. 
(Arlington Heights, IL).  [32P]dCTP (3,000  Ci/mmol) was obtained from 
New England Nuclear (Boston,  MA).  Receptor-grade EGF and HPLC- 
purified PDGF were obtained from Collaborative Research Inc. (Lexington, 
MA).  Insulin, aphidicolin, putrescine, and progesterone were purchased 
from Sigma Chemical Co.  (St.  Louis,  MO).  For routine use,  EGF was 
stored as  an  aqueous  solution,  insulin  was  stored  in  0.1  N  HCI,  and 
aphidicolin was stored in absolute ethanol. Antiserum against human mus- 
cle CPK,  which cross reacts  with the mouse enzyme,  was  generously 
provided by Ventrex Co. (Portland, ME). All other chemicals were reagent 
grade. 
Cell Culture 
BC3H1  cell  monolayers (27) were grown and  maintained at  37~  in  a 
humidified atmosphere containing 95%  air  and  5%  CO2  in T-75 flasks 
(Corning Glass Works,  Coming, NY) with DME supplemented with 10% 
heat-inactivated FCS (Gibco, Grand Island, NY or HyClone Laboratories, 
Logan, UT), penicillin (100 U/ml), and streptomycin (100 ~tg/ml).  Cells 
were kept subconfluent by subculturing twice a week as described (31). For 
experiments in this report, cells from passages 10 to 20 were cultured in 
35-mm dishes. 
To initiate cell differentiation or to test the effects of growth factors on 
this process, cells were placed in N2 serum-free (N2SF) modified hormone- 
supplemented medium  (3)  containing  RPMI-1640,  5  p.M  BSA  (Miles 
Laboratories Inc., Naperville, IL; Pentex, fatty acid-free), 5 ~tg/ml insulin, 
100  ~tg/ml transferrin, 20 nM progesterone,  100  ~tM putrescine, 30 nM 
Na2SeO3, and 10 mM Hepes buffer solution, pH 7.2.  Confluent cells were 
rinsed and incubated in N2SF medium, with growth factors added when in- 
dicated, for 4 d except where otherwise indicated. Cells were then radiola- 
beled as described below. 
Radioactive Labeling of Cells 
Cells were incubated in methionine-deficient DME supplemented with 90 
~tCi/ml  L-[35S]methionine  for 4  h at 37~  The labeled monolayers were 
washed twice with PBS and scraped off the dishes in 1 ml of PBS. The cells 
were then collected by centrifugation in a microfuge (Beckman Instruments, 
Inc., Palo Alto, CA) for 3 min. Cell pellets were dissolved in 70 ~tl of the 
9 M urea-containing lysis buffer described by O'Farrell (18). 
Electrophoretic Analysis of  Labeled Proteins 
Two-dimensional gel  electrophoresis was  performed essentially  as  de- 
scribed by O'Farrell (18), except that a modified IEF protocol was used (8). 
The IEF gels were prefocused for 15 rain at 300 V, 30 min at 650 V, and 
30 min at 1,000 V. After sonicating for 10-15 s, 20 p.l of the [35S]methio- 
nine-labeled cell lysate was subjected to IEF in a pH 5-7 gradient at 1,000 V 
for 16 h. Throughout the prefocusing and focusing, the gel system was main- 
tained at 18~  Gels were then processed for electrophoresis on 10% poly- 
acrylamide slab gels containing SDS. After autoradiography, spots of in- 
terest were excised from the dried gels and quantitated by liquid scintillation 
counting. Experiments were performed in triplicate, and gels of samples 
from three independent cultures were analyzed. 
Analysis of Total Cell Actin by 
DNAse I Affinity Chromatography 
The experiment was performed essentially as described previously (15, 37). 
Cells were labeled with [3SS]methionine for 4 h as described above. Cells 
were then harvested, sonicated in a buffer containing 10 mM Tris-HCl, pH 
7.4,  0.2 mM CaC12, 0.2 mM ATE  10%  formamide. A small aliquot was 
reserved for determination of total cell protein. The remaining solution was 
applied to a 0.6-ml  column of DNAse I-agarose and the actin isolated as 
described previously (156, 37).  For each determination, triplicate plates 
were analyzed in parallel, and the results are expressed as cpm labeled actin 
+SD/pg cell protein. 
Analysis of CPK Activity 
CPK activity was determined as described previously (14, 20), except that 
the concentration of NP-40 was reduced to 0.2 % in the solution used to ho- 
mogenize the cells so that protein concentrations could be analyzed with the 
protein assay from Bio-Rad Laboratories (Richmond, CA). CPK activity 
was assayed using a CPK reaction kit (Sigma Chemical Co.), and the results 
were normalized to total  cell protein. 
Immunoprecipitation of CPK 
Cells from a 35-mm dish were labeled for 4 h in the presence of [35S]me- 
thionine, harvested, and sonicated in Tris buffer,  pH 7.4,  containing 1% 
NP-40, 2 mM EDTA, 0.15 M NaCI, 1 mM PMSF, and 100 kallikrein inhibi- 
tor units/ml aprotinin. Immunoprecipitation of radioactively labeled CPK 
was performed essentially according to the procedure of Olson et al.  (19) 
using sufficient antiserum to completely remove all CPK from the sample. 
The immunoprecipitated protein was eluted from fixed killed Staphylococ- 
cus aureus  (Boehringer Mannheim Biochemicals, Indianapolis, IN) con- 
taining protein A, and the labeled protein was subjected to SDS gel elec- 
trophoresis.  For  each  precipitation equal  amounts  of total  labeled cell 
protein were used, and following immunoprecipitation, the entire sample 
was loaded on the gel. 
RNA Isolation and Characterization 
Preparation  of whole cell  RNA  was perfomed as previously described 
(5, 32). 
Northern analysis of BC3H1 cell RNA was performed as described previ- 
ously (32) using human skeletal muscle actin cDNA subjected to nick trans- 
lation (17) in the presence of [a-32P]dCTP  as a probe. The hybridization 
and washing were performed at 42~ 
Results 
Effect of  EGF on the Differentiation  of  BC  3H1 Cells 
When quiescent cells are cultured in serum-free medium for 
4 d, they differentiate into a muscle-like phenotype as pre- 
viously described (27). This change is reflected by an altera- 
tion of cell morphology from a fibroblast-like appearance to 
a long spindle-shaped appearance typical of muscle cells. At 
the same time, smooth muscle a-isoactin synthesis is stimu- 
lated (31) as is the synthesis of CPK and the acetylcholine 
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Figure 1.  Effects of EGF and aphidicolin on a-isoactin synthesis in 
differentiating BC3H1  cells.  Confluent  cells  were  placed  in  the 
medium  indicated.  At  selected  times  cells  were  labeled  with 
[35S]methionine and the percent newly labeled a-isoactin was de- 
termined as indicated in Materials and Methods. Each point shown 
represents the mean +SD of three independent samples. (e) N2SF; 
(o) N2SF containing 75 ng/ml EGF; (zx) N2SF containing 75 ng/ml 
EGF  +  5  gg/ml aphidicolin. 
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Figure 2.  Effect of EGF-induced  dedifferentiation  on a-isoactin 
synthesis in BC3H1 cells.  Cells differentiated 4 d in N2SF were 
placed in the medium indicated. At selected times, the cells were 
labeled with [3sS]methionine for 4 h, and the percent a-isoactin  of 
the total labeled actin was determined as described in Materials and 
Methods. Each point shown represents the mean +SD of three in- 
dependent  samples.  (e) N2SF;  (o) N2SF  +  75 ng/ml EGF;  (zx) 
N2SF  +  75 ng/ml EGF  +  5 ~tg/ml aphidicolin. 
Inclusion of EGF in the serum-free medium at the start 
of the  differentiation  process  prevents  the  morphological 
change usually observed in these cells (data not shown). In 
addition,  it prevents the induction of smooth muscle ct-iso- 
actin  synthesis  (Fig.  1).  Interestingly,  in  the  presence  of 
added EGF, the level of synthesis of this actin isoform rela- 
tive to the nonmuscle actins is actually lower than it is in cells 
grown in the presence of 10% FCS (Fig.  1). 
Effect of  EGF  Addition to Differentiated Cultures 
of  BC3H1 Cells 
Addition of EGF to 4-d differentiated cultures caused a de- 
crease in the amount of ct-isoactin synthesis relative to the 
synthesis of the nonmuscle 13- and T-actin isoforms (Fig. 2). 
To determine whether this relative change represented a de- 
crease in the actual amount of ct-isoactin synthesized,  we 
measured  the total amount of newly  synthesized actin by 
isolating labeled whole cell actin by DNAse I chromatogra- 
phy as described in Materials and Methods and normalizing 
the amount of radioactive actin to total cell protein. In one 
experiment, we obtained 1,130 +  110 cpm actin/ltg cell pro- 
tein in the control cells and 1,240  +  220 cpm actin/~tg cell 
protein  in cells dedifferentiated with EGF for  12  h.  In an 
identical experiment after 4  d  of treatment with EGF,  the 
values obtained were 990  +  130 cpm actin/vtg cell protein 
in the control and 920  +  130 cpm actin/Ixg cell protein in 
the treated cells. These results showed that there was no sig- 
nificant change in the amount of newly synthesized actin per 
microgram of cell protein after treatment of the differentiated 
cells with EGF. 
The results just described, combined with the data shown 
in Fig. 2 demonstrate that in cells dedifferentiated with EGF 
for 12 h, there is •46%  less newly synthesized a-isoactin 
and 39 % more of the newly synthesized 13- and 7-actin iso- 
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Figure 3. Effect of EGF-induced dedifferentiation on the turnover 
of(A) ct-isoactin and (B) 13- and 7-isoactins. Labeling of cells with 
[35S]methionine and  the  analysis  and  determination  of labeled 
isoactins are described  in Materials and Methods.  Cells differen- 
tiated 4 d in N2SF were pulse labeled for 4.5 h, washed with unla- 
beled N2SF, and then transferred to a chase medium consisting of 
N2SE  10 mM unlabeled methionine alone (e) or in the presence 
of 75 ng/ml EGF (o) for the indicated times. The radioactivity in 
each of the isoactin spots was normalized to the amount in each of 
the species on day 0. Each point represents the mean +SD of three 
independent samples. 
forms in comparison with cells continuously grown in the 
absence of EGF over the same time period. For cells dedif- 
ferentiated for 4 d in EGF the absolute amount of newly syn- 
thesized  a-isoactin  decreases  by  32%  and  the  absolute 
amount of 13- and y-isoactins increases 22% compared with 
the control cells. 
We also determined whether dedifferentiation induced by 
EGF was accompanied by a selective change in the turnover 
of actin isoforms by studying the disappearance of pre-la- 
beled isoactins after the start of dedifferentiation. As shown 
in Fig.  3, there is a slower decrease in the relative level of 
labeled 13- and ~,-isoactins in dedifferentiating cells over a 3-d 
period when compared with that in differentiated cells in the 
absence of EGF over the same period of time. On the other 
hand, the turnover of a-isoactin is about the same under both 
growth conditions. These results inducate that not only is the 
synthesis of a-isoactin decreased relative to the 13- and "y-iso- 
forms, but that the existing 13- and 7-isoactins are selectively 
stabilized during dedifferentiation. 
Effects of  EGF on CPK Levels in BC3H1 Cells 
We next investigated whether the effects we observed with 
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in BC3H1 Cells 
Growth condition  CPK  activity 
IU/mg protein 
Differentiation 
N2SF  0.70  +  0.05 
N2SF  +  EGF  0.06  +  0.01 
N2SF  +  EGF  +  aphidicolin  0.07  +  0.01 
Dedifferentiation 
N2SF  1.22  +  0.12 
N2SF  +  EGF  0.61  +  0.03 
N2SF  +  EGF  +  aphidicolin  0.60  +  0.03 
In the differentiation experiment, confluent cells were transferred into the indi- 
cated medium for 4d, and the CPK activity was then determined as described 
in Materials and Methods.  For the dedifferentiation experiment, differentiated 
cells that had been growing 4 d in N2SF medium were transferred to the medi- 
um indicated for an additional 4 d, and the CPK activity in the cells was then 
determined as indicated in the text.  Each value shown is the mean  +SD  of 
three independent samples. For these experiments, EGF was used at 75 ng/ml 
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Figure 5. Concentration depen- 
dence of the inhibition of ct-iso- 
actin synthesis on EGF.  Con- 
fluent cultures were transferred 
to  N2SF  medium  containing 
the level of EGF indicated.  Af- 
ter a 4-d incubation, the cells 
were labeled with [35S]methi- 
onine and the percent labeled 
ct-isoactin was calculated as de- 
scribed in Materials and Meth- 
ods. Each point represents the 
mean  +SD of three indepen- 
dent samples. 
EGF were specific for cytoskeletal and contractile  proteins 
or whether they occurred  as well on muscle-specific meta- 
bolic enzymes such  as CPK  whose  synthesis  is  stimulated 
during  the  BC3H1  cell  differentiation  process  (19).  Our 
results,  shown  in Table I,  demonstrate  that in cells treated 
with  EGF  to  prevent  differentiation,  CPK  activity  is  in- 
hibited 91% relative to the activity observed in differentiated 
cells.  Immunoprecipitation  of metabolically  labeled  CPK 
from differentiated cells and cells treated with EGF at the be- 
ginning of growth in serum-free medium showed that this in- 
hibition of CPK activity was actually due to an inhibition of 
enzyme synthesis  (Fig.  4). 
Treatment  of  differentiated  cells  with  EGF  to  induce 
dedifferentiation also resulted in a decrease in CPK activity 
(Table  I).  Again,  immunoprecipitation  experiments  indi- 
cated that this decrease could be largely accounted  for by a 
decrease in the synthesis of CPK. Equal amounts of radioac- 
tively labeled total and cells dedifferentiated  4  d  with EGF 
Figure 4. Immunoprecipitation 
of [35S]methionine-labeled CPK 
from undifferentiated  and dif- 
ferentiated  cells.  The  exper- 
iment  was  performed as  de- 
scribed in Materials and Meth- 
ods and  an autoradiogram of 
the gel was generated.  (A) CPK 
from cells differentiated 4 d in 
N2SF medium. (B) CPK from 
undifferentiated cells incubated 
for 4 d in N2SF medium con- 
mining 75 ng/ml EGE (*) De- 
notes the position of CPK with 
an apparent molecular mass of 
40 kD. O, origin. BPB; Brom- 
phenol blue marker. 
were subjected to immunoprecipitation,  and the precipitate 
was further resolved on SDS gels. Scanning of the CPK band 
from three separate experiments showed that the band inten- 
sity from the dedifferentiated cells was 0.22,  0.20,  and 0.27 
of that in the respective differentiated cells. These results in- 
dicate that as well as controlling  the differential expression 
of actin  isoforms,  EGF  can  also  inhibit  the  expression  of 
CPK  in  these cells. 
EGF Dose-Response Study 
To  determine  whether  the  effects  observed  in  response  to 
EGF occurred at physiological levels of the growth factor, we 
performed a  dose-response  study  with  EGF  at concentra- 
tions varying between 0  and  30 ng/ml.  The results,  shown 
in Fig.  5,  indicate that the half-maximal inhibition of ct-iso- 
actin synthesis occurs at 3-5 ng/ml,  whereas the maximum 
inhibition is observed at •30  ng/ml. The half-maximal effect 
is in the range seen for other EGF responsive processes (4, 
9,  25,  33). 
Effects of  Insulin on the Differentiation of 
BC3H1 Cells 
Insulin has been shown to promote cell differentiation in 313 
cells (10),  and it has also been shown to potentiate or to act 
synergistically  with other  growth  factors in promoting cell 
proliferation (12,  28).  Since insulin  at 5  ~tg/ml is a  compo- 
nent of N2SF medium, it is important to know whether it is 
required along with EGF to produce the effects we have ob- 
served. We thus tested media with different combinations of 
these two factors for their effects on BC3H1 cell differentia- 
tion.  The results presented in Table II show that whether in- 
sulin is totally excluded or present at a reduced concentration 
in the medium, EGF inhibits a-isoactin synthesis to the same 
extent it does in regular N2SF,  demonstrating that EGF ex- 
erts  its effect in an insulin-independent  fashion. 
Even though insulin does not influence the effects of EGF, 
it appears to be required for maximal differentiation of these 
cells. When insulin was omitted from the N2SF medium dur- 
ing cell differentiation,  the observed levels of a-isoactin syn- 
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Total Protein Synthesis in BC3H1 Cells 
Additions  a-lsoactin  Total protein 
% total labeled  cpm/dish 
actin  ( ￿ 10-  z) 
None  39.4  _+  2.2  t.07  +  0.05 
EGF  8.0  +  1.5  4.64  +  0.34 
5  ng/ml insulin  38.1  +  1.8  1.14  +  0.16 
5  ng/ml insulin  +  EGF  8.9  +  1.0  4.71  +  0.19 
50 ng /ml  insulin  50.2  +  2.6  1.55  +  0.09 
50 ng/ml insulin  +  EGF  9.8  +_  1.3  4.76  +  0.20 
5,000  ng/ml insulin  52.1  _+  0.3  3.88  +  0.14 
The basic medium used in this experimem is insulin-deficient N2SF. EGF was 
used at 75 ng/ml. Confluent cells were placed in the medium indicated for 4 d 
and labeled with [35S]methionine, and the  labeled isoactins were analyzed as 
described  in Materials and Methods.  Each value shown is the mean  +SD of 
three  independent samples. 
thesis  were  only  ~80%  as  high  as  the  insulin-containing 
control (Table II). 
Relationship between the Mitogenic Effect of EGF 
and Its Effect on a-lsoactin Synthesis 
We next studied whether EGF could stimulate cell prolifera- 
tion in BC3H1 cells and,  if so, whether its ability to inhibit 
the expression of r  was dependent on its mitogenic 
properties.  Differentiated  cells were treated  with EGF,  and 
the  cell  number  per  plate  was  determined.  The  results, 
shown in Table III, indicate that addition of EGF for 48 h 
to  a  differentiated  culture  (4  d  incubation  in  serum-free 
medium)  resulted  in  a  75-80%  increase  in  cell  number. 
When 20% serum was used as a mitogenic stimulus for com- 
parison, a doubling of the cells occurred over the same time. 
Thus EGF itself was able to produce almost the same degree 
of cell proliferation as did 20%  serum.  Insulin was not re- 
quired for EGF to exhibit its mitogenic effect on these cells. 
However, the absence of insulin resulted in an overall lower- 
ing of the cell number either because of increased cell death 
or cell shedding (Table III). 
We then studied whether the effect of EGF on r 
synthesis in differentiating cells was independent of  the mito- 
genic effects of EGE To do this, we added 5 Ixg/ml aphidico- 
lin (11), a specific inhibitor of DNA polymerase-ct, with EGF 
Table III.  The Mitogenic Effect of  EGF in 
Differentiated BC3H1 Cells 
Additions  Cell number/dish 
xlO-* 
None  61  +  8 
EGF  107  +  8 
20%  FCS  134  +  4 
Insulin  100  +  9 
Insulin +  EGF  178  +  2 
Insulin +  20%  FCS  219  +  8 
Confluent cells in 35-mm dishes were differentiated in N2SF medium for 4 d 
and were then transferred to insulin-deficient N2SF medium supplemented with 
growth factors or serum as indicated. Insulin was used at 5 lttg/ml, and EGF 
was used at 75 ng/ml. After incubation for 48 h, triplicate cultures from each 
growth  condition  were  trypsinized  with 0.05%  trypsin,  and  the cells  were 
pelleted in DME plus 10%  FCS and resuspended in I ml PBS. Cell numbers 
of the suspensions were counted in quadruplicate  with a hemocytometer and 
expressed as the mean  :I:SD. 
Figure 6. Northern analysis of the muscle and nonmuscle isoactin 
mRNAs in BC3H1  cells grown under different  conditions.  The 
Northern analysis was performed as described in the Materials  and 
Methods. 40 ~tg of RNA was loaded per lane. Thus, the band inten- 
sity observed reflects the actual amount of each actin mRNA pres- 
ent in the cells in the various stages tested allowing for lane to lane 
comparison. The radioactive  band at 2.1 kb represents  the 13 and 
nonmuscle isoactin mRNAs while the band at 1.5 kb represents 
the ct-isoactin mRNA as described previously (32). The autoradio- 
gram of the Northern blot was analyzed by scanning densitometry 
using an Eikonix digital camera system in the University of Iowa 
Image Analysis  Facility. The percent intensity  of the  1.5-kb band 
was calculated  by dividing the intensity  of the 1.5-kb band by the 
sum of  the intensities of the two bands, and the results are displayed 
in the histogram.  (A) For lanes 1-4, RNA was collected  4 d after 
transfer of  confluent cells to the medium indicated.  (Lane 1) N2SF; 
(lane 2) N2SF +  75 ng/ml EGF; (lane 3) insulin-deficient  N2SF; 
(lane 4) insulin-deficient  N2SF containing 75 ng/ml EGF; (lane 5) 
cells differentiated for 4 d in N2SF (differentiated cells) were placed 
for 4 d in fresh N2SF; (lane 6) differentiated  cells were placed for 
4 d in N2SF containing 75 ng/ml EGF; (lane 7) confluent cells be- 
fore the start  of differentiation  in N2SE (B) Effect of short-term 
dedifferentiation  on ct-isoactin mRNA. For all lanes, 4-d differen- 
tiated cultures  were used. (Lane 1 ) Starting  cells; (lane 2) 12 h in 
fresh N2SF; (lane 3) 12 h in N2SF +  EGF; (lane 4) 12 h in N2SF 
+  20%  FCS. 
in serum-free medium.  This concentration of aphidicolin is 
sufficient to inhibit DNA synthesis >97% (data not shown). 
Under  these  conditions,  the  inhibitory  effect  of EGF  on 
a-isoactin synthesis remained unchanged both in the differ- 
entiation  (Fig.  1)  and  dedifferentiation  (Fig.  2)  processes. 
Identical results were also seen on the repression of CPK ac- 
tivity (Table I). These results show that the effect of EGF on 
the inhibition of the synthesis of these muscle-specific pro- 
teins occurs independent  of its effect on DNA synthesis. 
Analysis of a-Isoactin mRNA Levels in Differentiated 
and Dedifferentiated Cells 
Previous work from our laboratory showed that the induction 
of smooth muscle a-isoactin synthesis was accompanied by 
a significant increase in the level of ct-isoactin mRNA (32). 
We wished to determine whether the effect caused by EGF 
on ct-isoactin synthesis in these cells occurred in conjunction 
with a change in the levels of the mRNAs for the muscle and 
nonmuscle isoactins. 
We carried out a  Northern analysis on RNA samples ob- 
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probe, we used a human skeletal muscle a-isoactin cDNA 
previously shown to hybridize to the mRNAs for both muscle 
and nonmuscle actin isoforms (32). The findings shown in 
Fig. 6 are representative of three different experiments car- 
ried out, and equal amounts of total cell RNA were loaded 
in each lane of the gel. The results in Fig. 6 A indicate first 
that a-isoactin mRNA accumulates during the differentiation 
phase relative to the mRNAs for the nonmuscle actin iso- 
forms (lanes 1 and 7), and addition of EGF to N2SF prevents 
this accumulation (lane 2).  Omission of insulin during the 
differentiation phase results in a smaller increase in the rela- 
tive level of a-isoactin (lane 3) mRNA compared to the case 
when insulin is included. Lane 4 demonstrates that insulin 
is not required for the suppression of a-isoactin mRNA level 
resulting from the addition of EGF to N2SE Finally, when 
dedifferentiation is caused by the addition of EGF for 4 d, 
a  significant  decrease  in  the  relative  level  of r 
mRNA occurs compared to the control in fully differentiated 
cells (lanes 5 and 6). Fig. 6 B shows that in as short a time 
as 12 h after addition of either EGF or 20%  FCS, there is 
a  22-25 %  decrease in  the  amount of ct-isoactin mRNA. 
Thus,  for  both  differentiating and  dedifferentiating cells, 
changes  in  a-isoactin  levels  are  accompanied by  similar 
changes in the levels of its mRNA. Early in dedifferentiation, 
the decrease in  a-isoactin mRNA  does not equal the de- 
crease in the synthesis of r  possibly suggesting the 
operation of translational control in this process as well. 
Discussion 
The differential change observed in isoactin synthesis can be 
accounted for by changes in the levels of the muscle and non- 
muscle isoactin mRNAs.  During dedifferentiation, there is 
also a selective stabilization of the nonmuscle isoactins, pos- 
sibly due to the preferential use and subsequent protection 
of the nonmuscle actin isoforms at this time. 
In our hands, EGF controls the synthesis of CPK during 
differentiation and dedifferentiation in a manner parallel with 
smooth muscle r  as determined both by the mea- 
surement of enzyme activities and by immunoprecipitation 
of newly synthesized CPK. This observation indicates that 
EGF may coordinately control the expression of a number 
of muscle-specific  proteins.  Furthermore,  although  EGF 
acts as a mitogen for these cells, this activity is not required 
for EGF to inhibit the synthesis of these muscle-specific pro- 
teins. It has been shown in other cells as well that EGF can 
cause major effects in specific gene expression independent 
of its ability to act as a mitogen (13). Furthermore, in BC3H1 
cells, Spizz et al.  (29) reported a similar finding for FGE 
When assessing the effects of EGF during the dedifferenti- 
ation process, we noticed that in the control cells maintained 
in serum-free medium, there is a continuous increase in the 
level of muscle actin mRNA relative to that of nonmuscle ac- 
tin mRNA (compare lanes 1 and 5 in Fig. 6 A). There was 
not, however, a concomitant increase in the percent of newly 
synthesized ct-isoactin relative to the nonmuscle isoforms 
during this time (control; Fig. 2). This discrepancy may be 
due either to an isoform-specific translational control or it 
may  result  from  the  synthesis  of nontranslatable  1.5-kb 
mRNA that will still hybridize with the actin clone. We can- 
not at this time distinguish between these possibilities. 
Inclusion of insulin in the serum-free medium potentiates 
the degree of differentiation achieved by these cells.  How- 
ever, the concentrations of insulin required for this effect are 
much higher than those needed to exert an effect through the 
high affinity insulin receptor (30). Although high affinity in- 
sulin receptors have been detected in BC3H1 cells (30), our 
particular subclone does not express these (Pessin, J., per- 
sonal communication). Since insulin at high concentrations 
also binds to the insulin-like growth factor-I (ILGF-I) recep- 
tor (7) which is present in our cells (Ginsberg, B., personal 
communication), the insulin effect we observed was proba- 
bly mediated via the ILGF-I receptor. Interestingly, in pri- 
mary smooth muscle cell cultures, ILGF-I, working presum- 
ably through the same receptor, exhibits the opposite effect: 
promotion of cell proliferation (6, 9,  24). 
Our results are in disagreement with those of Lathrop et 
al. (14) and Olson et al. (21) who reported that EGF had no 
effect in BC3H1 cells. Their protocols differed from ours in 
that their differentiated cells were grown on collagen layers 
in 0.5 % serum while our cells were differentiated in serum- 
free medium and grown on plastic.  When we substituted 
their culture conditions individually for ours, however, the 
EGF effects were still observed. Thus, the most likely expla- 
nation for our differing results is that we have a different sub- 
clone of the cell line which responds to EGF whereas theirs 
does not. Growth of our cells on a collagen layer did seem 
to produce a more pronounced differentiated phenotype in 
terms  of the  amount  of ct-isoactin  expression  (data  not 
shown). We agree with Lathrop et al.  (14) and Olson et al. 
(21) that PDGF has no observable effect on BC3H1 cell dif- 
ferentiation.  Thus,  these  cells  do  not  require  exogenous 
PDGF to make them competent before becoming sensitive 
to the influence of EGF. 
The effects we observed with EGF during the dedifferenti- 
ation process are similar to those reported by Wice et al. (36) 
for fibroblast growth factor. This observation suggests that 
these two factors at some point may work through similar 
pathways  after binding of the growth factors to their recep- 
tors.  Finding this connection will be important in under- 
standing the nature of the control of differentiation in these 
cells. 
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